Home
Arnold & Porter
Ludovica Pizzetti
Ludovica Pizzetti
Arnold & Porter
Virtual And Digital Health Digest
27 Oct 2023 | Worldwide
How The UK Investment Screening Regime Is Taking Shape
27 Sep 2023 | UK
UK National Security Review
16 Aug 2023 | UK
Virtual And Digital Health Digest
25 Jan 2023 | Worldwide
Virtual And Digital Health Digest
21 Dec 2022 | United States
Takeaways For Transaction Parties After UK Acquisition Block
14 Dec 2022 | UK
UK Government Unwinds Chinese Acquisition Of Welsh Wafers
30 Nov 2022 | UK
Early Trends In UK National Security Reviews Of Transactions
26 Aug 2022 | Worldwide
UK National Security Reviews: Insight Into Emerging Trends After First Deal Gets Blocked
15 Aug 2022 | UK
The UK National Security And Investment Act 2021 (NSIA) – Implications For Life Sciences
22 Jun 2022 | UK
UK National Security And Investment Act 2021: What It Means For Life Sciences Transactions
21 Jun 2022 | UK
A New Mandatory UK Foreign Direct Investment Regime Gets Royal Assent: The Five Key Things You Need To Know
11 May 2021 | UK
CFIUS—CFIUK: New Additional National Security Review Of UK Acquisitions
03 Dec 2020 | UK
Merger Control In The UK—Three And A Half Things You Need To Know
17 Sep 2020 | UK
Competitor Cooperation In The Time Of COVID-19: Competition Law Suspended?
16 Jul 2020 | United States
Brexit And Merger Control: Expect A More Active UK Authority
03 Feb 2020 | UK
UK Merger Control Snapshot
01 Oct 2019 | UK
European Competition Enforcement In The Pharmaceutical Sector: More To Be Expected?
26 Mar 2019 | United States
Foreign Direct Investment Control In Europe: Helicopter View Of An Expanding Landscape
06 Mar 2019 | United States
BritNed Developments v. Abb Revisited: UK High Court Rules Further Reduction In Damages And No Order As To Costs In Follow-On Competition Litigation
29 Nov 2018 | United States
< 1 2 >
20%
Very Popular: This author falls within the Top 20% for the below topics and industry categories
Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States for the topics, user groups and industry sectors listed below*:
Topics
  • Food and Drugs Law
  • Life Sciences, Biotechnology & Nanotechnology
  • Privacy
  • Security
  • Technology
  • Food, Drugs, Healthcare, Life Sciences
  • Privacy Protection
  • Healthcare
* Rankings are based on analysis of the last 12 months of Mondaq readership data across more than 25,000 contributing authors. To be ranked ‘Very Popular’ an author must be in the top 20% of results within the selected criteria.
Contact Details
Washington, DC
Email Website
Washington, DC
United States

  © Mondaq® Ltd 1994 - 2024. All Rights Reserved.